Candel Therapeutics Net Profit Margin Growth & History (CADL)
Candel Therapeutics's net profit margin was −15,035.20% for fiscal 2022.
View full Candel Therapeutics company overviewCandel Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −15,035.20% | +13864.00 pp |
| 2021 | 2021-12-31 | −28,899.20% | −14755.20 pp |
| 2020 | 2020-12-31 | −14,144.00% | — |
Candel Therapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −15,884.38% | −20871.88 pp |
| Q3 2022 | 2022-09-30 | −28,025.81% | +24109.68 pp |
| Q2 2022 | 2022-06-30 | −13,383.87% | +41712.90 pp |
| Q1 2022 | 2022-03-31 | −2,819.35% | +11625.81 pp |
| Q4 2021 | 2021-12-31 | 4,987.50% | — |
| Q3 2021 | 2021-09-30 | −52,135.48% | −43896.77 pp |
| Q2 2021 | 2021-06-30 | −55,096.77% | −45819.35 pp |
| Q1 2021 | 2021-03-31 | −14,445.16% | — |
| Q3 2020 | 2020-09-30 | −8,238.71% | — |
| Q2 2020 | 2020-06-30 | −9,277.42% | — |
Candel Therapeutics net profit margin trends
Between the periods ended 2020-12-31 and 2022-12-31, Candel Therapeutics's net profit margin decreased from −14,144.00% to −15,035.20%, a change of −891.20 percentage points. The latest reported quarter, Q4 2022, shows −15,884.38%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Candel Therapeutics source filings ↗